AMERSA Talks
AMERSA Talks
Podcast Description
Harm Reduction: Compassionate Care for People who use DrugsEight 30-minute episodes sponsored by PCSS-MOUD and hosted by AMERSA members, featuring subject matter experts across multiple disciplines.
Podcast Insights
Content Themes
The podcast explores a range of harm reduction topics including emerging overdose detection technologies, managed alcohol programs, innovative access to treatment, and the challenges of harm reduction in pregnancy and parenting, with episode examples such as discussions on fentanyl contaminants in drug supplies and the impact of managed alcohol strategies in treating alcohol use disorder.
Two new Series Coming Soon in 2026!
Frontiers in Substance Use Care: Emerging Topics and Evidence
Eight episode podcast series sponsored by Provider’s Clinical Support System – Medication for Opioid Use Disorder (PCSS-MOUD), exploring the evolving landscape of substance use and addiction care.
Substance Use Across the Lifespan: Supporting Every Stage
Five episodes, each paired with a downloadable toolkit and live companion workshop, sponsored by the Opioid Response Network (ORN). This series explores how substance use care changes across the lifespan—from childhood through older adulthood.
Previous Series
Stigma and Substance Use: Rewriting the Narrative.
Eight episodes sponsored by Provider’s Clinical Support System – Medication for Opioid Use Disorder (PCSS-MOUD), exploring the pervasive impact of stigma on individuals and communities affected by substance use disorders (SUD).
Innovation in Action: Building Stronger Communities
Seven episodes sponsored by the Opioid Response Network (ORN), highlighting cutting-edge programs and collaborative efforts supporting individuals and communities affected by substance use disorders.
After you listen, please complete SAMHSA’s required Training and Technical Assistance (TTA) GPRA Post-Event Form. This form will gather satisfaction with the event to help improve future episodes.
For patients with cancer and substance use disorders, managing pain safely and effectively presents unique challenges. Clinicians must balance appropriate opioid prescribing with the risks of relapse, overdose, and fragmented care. This episode explores how addiction, oncology, and palliative care providers can work together to support both cancer treatment and recovery. Listeners will learn practical frameworks for managing cancer-related pain, coordinating care across specialties, and improving outcomes for patients navigating these intersecting and complex conditions.
Timestamps:
[06:42] Cancer Pain vs Other Pain
[09:22] Patient Education and Safety
[15:22] Active Use and MOUD Basics
[18:33] Adjuvants During Treatment
[20:47] Buprenorphine in Cancer Pain
[25:25] Choosing Bupe Products and Doses
[31:01] Methadone Logistics and Risks
[41:19] Survivorship and Chronic Pain
[48:39] Building Collaboration Systems
[53:07] Key Takeaways and Resources
Links :
Conversations that Matter: Engaging Patients around Pain and Substance Use – VitalTalk
Find us online at amersa.org/amersa-podcast
Frontiers in Substance Use & Stigma & Substance Use are sponsored by Provider’s Clinical Support System – Medication for Opioid Use Disorder (PCSS-MOUD). Learn more about PCSS-MOUD at pcssnow.org.
Funding for this initiative was made possible by cooperative agreement no. 1H79TI086770 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
Substance Use Across the Lifespan and Innovation in Actionare sponsored by the Opioid Response Network (ORN). Learn more about ORN at opioidresponsenetwork.org.
Funding for this initiative was made possible (in part) by grant no. 1H79TI088037 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.